Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Early paracentral visual field loss in patients taking hydroxychloroquine.

Elder M, Rahman AM, McLay J.

Arch Ophthalmol. 2006 Dec;124(12):1729-33.

PMID:
17159032
2.

Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.

Kellner U, Renner AB, Tillack H.

Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3531-8.

PMID:
16877425
3.

Hydroxychloroquine screening.

Lee AG.

Br J Ophthalmol. 2005 May;89(5):521-2. No abstract available.

4.

Retinopathy following chloroquine therapy.

HOBBS HE, SORSBY A, FREEDMAN A.

Lancet. 1959 Oct 3;2(7101):478-80. No abstract available.

PMID:
14402143
5.

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.

Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF; American Academy of Ophthalmology.

Ophthalmology. 2002 Jul;109(7):1377-82. No abstract available.

PMID:
12093666
6.

Hydroxychloroquine retinopathy.

Easterbrook M.

Ophthalmology. 2001 Dec;108(12):2158-9. No abstract available.

PMID:
11733247
7.

Detection of color vision defects in chloroquine retinopathy.

Vu BL, Easterbrook M, Hovis JK.

Ophthalmology. 1999 Sep;106(9):1799-803; discussion 1804.

PMID:
10485553
8.

Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy.

Shearer RV, Dubois EL.

Am J Ophthalmol. 1967 Aug;64(2):245-52. No abstract available.

PMID:
6036279
9.

Delayed onset of chloroquine retinopathy.

Burns RP.

N Engl J Med. 1966 Sep 29;275(13):693-6. No abstract available.

PMID:
5918106
10.

Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.

Finbloom DS, Silver K, Newsome DA, Gunkel R.

J Rheumatol. 1985 Aug;12(4):692-4.

PMID:
4057189
11.

Delayed-onset chloroquine retinopathy.

Ehrenfeld M, Nesher R, Merin S.

Br J Ophthalmol. 1986 Apr;70(4):281-3.

12.

Hydroxychloroquine therapy in massive total doses without retinal toxicity.

Johnson MW, Vine AK.

Am J Ophthalmol. 1987 Aug 15;104(2):139-44.

PMID:
3618711
13.

Long-term course of antimalarial maculopathy after cessation of treatment.

Easterbrook M.

Can J Ophthalmol. 1992 Aug;27(5):237-9.

PMID:
1393809
14.

Delayed onset chloroquine retinopathy: case report.

Martin LJ, Bergen RL, Dobrow HR.

Ann Ophthalmol. 1978 Jun;10(6):723-6.

PMID:
677653
15.

Long-term course of chloroquine retinopathy after cessation of medication.

Brinkley JR Jr, Dubois EL, Ryan SJ.

Am J Ophthalmol. 1979 Jul;88(1):1-11.

PMID:
463998

Supplemental Content

Support Center